Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection

Transplantation

Volumn 83, Issue 2, 2007, Pages 150-158

  Bharat, Ankit ^a   Narayanan, Kishore ^a   Street, Tyler ^a   Fields, Ryan C ^a   Steward, Nancy ^a   Aloush, Aviva ^a   Meyers, Brian ^a   Schuessler, Richard ^a   Trulock, Elbert P ^a   Patterson, G Alexander ^a   Mohanakumar, Thalachallour ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alloimmunity; Bronchiolitis obliterans syndrome; HLA class II; Inflammation; Lung transplantation

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CYCLOSPORIN; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIBODY; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 14; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RANTES; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLOIMMUNITY; ARTICLE; BRONCHIOLITIS OBLITERANS; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HLA MATCHING; HLA SYSTEM; HUMAN; IMMUNOASSAY; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POSTOPERATIVE INFLAMMATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; TH1 CELL;

BRONCHIOLITIS OBLITERANS; CHRONIC DISEASE; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LUNG; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; TH1 CELLS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33846638258     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000250579.08042.b6     Document Type: Article

References (47)

1. Morita K, Miura M, Paolone DR, et al. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection. J Immunol 2001; 167(5): 2979.
2. el-Sawy T, Fahmy NM, Fairchild RL. Chemokines: directing leukocyte infiltration into allografts. Curr Opin Immunol 2002; 14(5): 562.
3. Krensky AM, Weiss A, Crabtree G, et al. T-lymphocyte-antigen interactions in transplant rejection. N Engl J Med 1990; 322(8): 510.
4. Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338(25): 1813.
5. Halloran PF, Homik J, Goes N, et al. The "injury response": a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc 1997; 29(1-2): 79.
6. Reznik SI, Jaramillo A, Zhang L, et al. Anti-HLA antibody binding to hla class I molecules induces proliferation of airway epithelial cells: a potential mechanism for bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 2000; 119(1): 39.
7. Boehler A, Kesten S, Weder W, Speich R. Bronchiolitis obliterans after lung transplantation: a review. Chest 1998; 114(5): 1411.
8. Reznik SI, Jaramillo A, SivaSai KS, et al. Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Am J Transplant 2001; 1(3): 228.
9. Girgis RE, Tu I, Berry GJ, et al. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant 1996; 15(12): 1200.
10. SivaSai KS, Smith MA, Poindexter NJ, et al. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Transplantation 1999; 67(8): 1094.
11. Lu KC, Jaramillo A, Mendeloff EN, et al. Concomitant allorecognition of mismatched donor HLA class I- and class II-derived peptides in pediatric lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant 2003; 22(1): 35.
12. Jaramillo A, Smith MA, Phelan D, et al. Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation 1999; 67(8): 1155.
13. Sundaresan S, Mohanakumar T, Smith MA, et al. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation 1998; 65(5): 648.
14. Smith MA, Sundaresan S, Mohanakumar T, et al. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 1998; 116(5): 812.
15. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996; 15(1 Pt 1): 1.
16. Bharat A, Fields RC, Steward N, et al. CD4+CD25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human transplantation. Am J Transplant 2006; 6(8): 1799.
17. Fields RC, Bharat A, Steward N, et al. Elevated soluble CD30 correlates with development of bronchiolitis obliterans syndrome following lung transplantation. Transplantation 2006; in press.
18. Jaramillo A, Majumder K, Manna PP, et al. Identification of HLA-A3-restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer. Int J Cancer 2002; 102(5): 499.
19. Jaramillo A, Fernandez FG, Kuo EY, et al. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant 2005; 9(1): 84.
20. van den Berg JW, Hepkema BG, Geertsma A, et al. Long-term outcome of lung transplantation is predicted by the number of HLA-DR mismatches. Transplantation 2001; 71(3): 368.
21. Chalermskulrat W, Neuringer IP, Schmitz JL, et al. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation. Chest 2003; 123(6): 1825.
22. Heng D, Sharples LD, McNeil K, et al. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 1998; 17(12): 1255.
23. Heeger PS. T-cell allorecognition and transplant rejection: a summary and update. Am J Transplant 2003; 3(5): 525.
24. Rogers NJ, Lechler RI. Allorecognition. Am J Transplant 2001; 1(2): 97.
25. Lau CL, Palmer SM, Posther KE, et al. Influence of panel-reactive antibodies on posttransplant outcomes in lung transplant recipients. Ann Thorac Surg 2000; 69(5): 1520.
26. Jaramillo A, Smith CR, Maruyama T, et al. Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome. Hum Immunol 2003; 64(5): 521.
27. Jaramillo A, Zhang L, Mohanakumar T. Binding of anti-HLA class I antibodies to airway epithelial cells induces activation and growth factor production and indirectly upregulates lung fibroblast proliferation. J Heart Lung Transplant 2001; 20(2): 166.
28. Sawyer GJ, Dalchau R, Fabre JW. Indirect T cell allorecognition: a cyclosporin A resistant pathway for T cell help for antibody production to donor MHC antigens. Transpl Immunol 1993; 1(1): 77.
29. Palmer SM, Davis RD, Hadjiliadis D, et al. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome. Transplantation 2002; 74(6): 799.
30. Smith CR, Jaramillo A, Duffy BF, Mohanakumar T. Airway epithelial cell damage mediated by antigen-specific T cells: implications in lung allograft rejection. Hum Immunol 2000; 61(10): 985.
31. Mauck KA, Hosenpud JD. The bronchial epithelium: a potential allogeneic target for chronic rejection after lung transplantation. J Heart Lung Transplant 1996; 15(7): 709.
32. Nakajima J, Ono M, Takeda M, et al. Role of costimulatory molecules on airway epithelial cells acting as alloantigen-presenting cells. Transplant Proc 1997; 29(4): 2297.
33. Belperio JA, Keane MP, Burdick MD, et al. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J Clin Invest 2001; 108(4): 547.
34. Belperio JA, Keane MP, Burdick MD, et al. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 2002; 169(2): 1037.
35. Melter M, Exeni A, Reinders ME, et al. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 2001; 104(21): 2558.
36. Zhao DX, Hu Y, Miller GG, et al. Differential expression of the IFN-gamma-inducible CXCR3-binding chemokines, IFN-inducible protein 10, monokine induced by IFN, and IFN-inducible T cell alpha chemoattractant in human cardiac allografts: association with cardiac allograft vasculopathy and acute rejection. J Immunol 2002; 169(3): 1556.
37. Loetscher M, Gerber B, Loetscher P, et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996; 184(3): 963.
38. Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997; 15: 675.
39. + regulatory T-cells leads to the development of collagen-V specific autoimmunity in patients with chronic human lung allograft rejection. Presented at the 2005 American Transplant Congress Annual Meeting, Seattle, WA.
40. Christopher K, Mueller TF, Liang Y, et al. Modulation of gene expression by alloimmune networks following murine heart transplantation. Mol Genet Genomics 2004; 271(6): 687.
41. Lu KC, Jaramillo A, Lecha RL, et al. Interleukin-6 and interferon-gamma gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2002; 74(9): 1297.
42. Marshall SE, Welsh KI. The role of cytokine polymorphisms in rejection after solid organ transplantation. Genes Immun 2001; 2(6): 297.
43. Gorczynski RM. Role of cytokines in allograft rejection. Curr Pharm Des 2001; 7(11): 1039.
44. Elssner A, Jaumann F, Dobmann S, et al. Elevated levels of interleukin-8 and transforming growth factor-beta in bronchoalveolar lavage fluid from patients with bronchiolitis obliterans syndrome: proinflammatory role of bronchial epithelial cells. Munich Lung Transplant Group. Transplantation 2000; 70(2): 362.
45. Ross DJ, Moudgil A, Bagga A, et al. Lung allograft dysfunction correlates with gamma-interferon gene expression in bronchoalveolar lavage. J Heart Lung Transplant 1999; 18(7): 627.
46. Scholma J, Slebos DJ, Boezen HM, et al. Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation. Am J Respir Crit Care Med 2000; 162(6): 2221.
47. Meloni F, Vitulo P, Cascina A, et al. Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome. J Heart Lung Transplant 2004; 23(9): 1053.